MIRA (MIRA Pharmaceuticals, Inc. Common Stock) Stock Analysis - AI Report

MIRA Pharmaceuticals, Inc. Common Stock (MIRA) is a publicly traded Healthcare sector company. As of May 21, 2026, MIRA trades at $0.98 with a market cap of $41.01M and a P/E ratio of -0.72. MIRA moved +0.00% today. Year to date, MIRA is -35.06%; over the trailing twelve months it is -26.14%. Its 52-week range spans $0.73 to $2.56. Rallies surfaces MIRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on MIRA?

Rallies AI research for MIRA combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

MIRA Key Metrics

Key financial metrics for MIRA
MetricValue
Price$0.98
Market Cap$41.01M
P/E Ratio-0.72
EPS$-1.35
Dividend Yield0.00%
52-Week High$2.56
52-Week Low$0.73
Volume464
Avg Volume0
Revenue (TTM)$0
Net Income$-10.44M
Gross Margin0.00%

Latest MIRA News

Recent MIRA Insider Trades

  • Aminov Erez sold 613.60K (~$1.29M) on Oct 16, 2025.
  • Aminov Erez sold 44.59K (~$56.63K) on Nov 20, 2024.
  • Aminov Erez sold 55.41K (~$77.02K) on Nov 19, 2024.

MIRA Analyst Consensus

MIRA analyst coverage data. Average price target: $0.00.

Common questions about MIRA

What is the AI research view on MIRA?
Rallies AI research for MIRA combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for MIRA?
Rallies AI research for MIRA combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is MIRA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for MIRA. It does not provide personalized investment advice.
MIRA

MIRA